1 Familial Hypercholesterolemia (FH): Premature Cardiovascular Risk Reduction Through Early Action.

Slides:



Advertisements
Similar presentations
Replacement of Defective Genes A story of familial hypercholesterolemia By, Russell Brown, Amber Ellis, and Stacey Leonard.
Advertisements

Lipoprotein Structure, Function, and Metabolism
Lipoprotein Metabolism And Disorders
Genetics of Lipoprotein Disorders
Metabolism of VLDL Dr. Nikhat Siddiqi.
Cholesterol and Heart Disease. Plaques Buildup in arteries is composed of proteins, lipids, and cholesterol When blood vessels are plugged up, you get.
Cholesterol transport and uptake Dr. Carolyn K. Suzuki 1.
Metabolism of HDL Dr Nikhat Siddiqi.
Cholesterol and C.V.D.. Learning outcome Most cholesterol is synthesised by the liver from saturated fats in the diet. Cholesterol is a component of cell.
By- Katherine Kauffman Vanessa Witmer. Brief Steroid Information Steroids are the third major class of lipids. Their structure is basically four rings.
Lipoprotein Structures, Function and Metabolism (1)
Dov Gavish MD הטיפול בחולים בסיכון גבוה לאור המלצות ESC מאי 2013 ההסתדרות הרפואית בישראל – החברה לחקר, מניעה וטיפול בטרשת עורקים Israel Medical.
Familial Hypercholesterolemia Honors Genetics 2006.
Plasma lipoproteins. Generalized structure of a plasma lipoprotein.
Familial hypercholesterolemia is a disorder of high LDL ("bad") cholesterol that is passed down through families, which means it is inherited. The condition.
Membrane Functions Transport Systems Enzyme Systems
LECT 22: LIPIDS, MEMBRANES, AND CHOLESTEROL Lipids and cholesterol in the body derive from food intake and from de novo synthesis. Phospholipids are principle.
 is a genetic disorder characterized by high cholesterol levels.  specifically very high levels of low-density lipoprotein in the blood and early cardiovascular.
Lesson 3 Slide 3.1 What might cause this disease?.
Lipoprotein Structures, Function and Metabolism (2)
Cholesterol Metabolism Southwestern Medical School Dallas, Texas.
The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)
Familial Hypercholesterolemia
Lipoproteins The serum lipoproteins are complexes of lipids and specific proteins called "apoproteins". Functions of Lipoproteins Help to transport lipids.
 Main lipids in the blood are the triglycerides and cholesterol.  Insoluble in the water.  Transport in the blood is via lipoproteins.
بسم الله الرحمن الرحيم.
Familial Hypercholesterolemia Scott Cooper, UW-La Crosse.
Lipid Homeostasis and Transport CH353 February 12, 2008.
Kristin Miller Caleb Conrad 13.9 What Are Steroids.
Abnormalities of LDL metabolism
Trends in Biomedical Science Theories of Alzheimer’s Disease.
Plug-n-Play with RNA Isaacs & Collins Deepti & John S.
Genetics of Familial Hypercholesterolemia 张咸宁 Tel : ; Office: A705, Research Building 2013/03.
Genetics of Familial Hypercholesterolemia
Genetics of Familial Hypercholesterolemia 张咸宁 Tel : ; Office: C303, Teaching Building 2016/03.
Low density lipoproteins, metabolism...Apolipoproteins: Role in Lipid Transport and Polymorphisms.
Lipids in the diet are hydrolyzed in the small intestine, and the resultant fatty acids and monoglycerides are repackaged with apoB-48 into TG-enriched.
KA 7d: Learning Outcomes
Lipoproteins and Atheroscloresis
Lipoproteins and Atheroscloresis
Cardiovascular Disease
بسم الله الرحمن الرحيم.
Evolocumab Drugbank ID : DB09303.
LIPOPROTEINS A to Z.
Regulator gene Produces a protein called the repressor molecule
Relation between the fractional catabolic rate (FCR) for plasma LDL and the number of LDL receptors on fibroblasts in patients with FH. The values for.
Robert Roberts, MD, FRCPC, MACC  Canadian Journal of Cardiology 
Is atherosclerosis a metabolic disease?
Control of Metabolic Pathways (2)
Familial Hypercholesterolemia
PCSK9 Loss-of-function Mutations PCSK9-Mediated Degradation of LDL-R.
Gene Regulation.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 1 Overview of lipoprotein metabolism and effects of novel lipid-modulating approaches Figure 1 | Overview of lipoprotein metabolism and effects.
Nat. Rev. Rheumatol. doi: /nrrheum
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia  Joep C. Defesche, PhD,
Hepatitis C virus entry and glucocorticosteroids
12/30/2018 OSTEOPOROSIS.
From Prescription to Transcription: Genome Sequence as Drug Target
HCV and the hepatic lipid pathway as a potential treatment target
APOC3, Coronary Disease, and Complexities of Mendelian Randomization
New Therapeutic Approaches to the Treatment of Dyslipidemia
L’antagoniste se lie à Blys
The Role of Apolipoprotein E in Alzheimer's Disease
Volume 19, Issue 2, Pages (February 2014)
(A) Missense mutations identified in different domains of ROR2 in recessive Robinow syndrome. (A) Missense mutations identified in different domains of.
Lipoprotein Metabolism
Potential Mechanisms of Adverse Outcomes Associated with Torcetrapib
Insights in the Understanding of Cholesterol Metabolism:
Three drug delivery strategies for crossing the blood-brain barrier.
Presentation transcript:

1 Familial Hypercholesterolemia (FH): Premature Cardiovascular Risk Reduction Through Early Action

2 3 Genes Affecting LDL Clearance Can Cause FH Mutations Identified to Date APOB (6 mutations identified) Codes for production of ligand protein, ApoB, which connects LDL particle to receptor Rader DJ, et al. J Clin Invest. 2003;111: LDL particle Liver cell Circulation LDLR (>1000 mutations) codes for LDL receptor which binds to ApoB on LDL particle inducing endocytosis of LDL PCSK9 (8 GOF mutations identified to date) codes for PCSK9 enzyme, which degrades the LDL receptor

3 Normally, LDL Receptors on hepatocytes help to clear LDL Particles from plasma LDL particle Liver cell Circulation Rader DJ, et al. J Clin Invest. 2003;111:

4 LDL Receptor (LDLR) Mutations Alter LDL Receptors, Preventing Attachment to Particle ApoB LDL particle LDL receptor LDL receptor binding site impaired function prevents binding to LDL particle Normal FH: LDLR- Rader DJ, et al. J Clin Invest. 2003;111:

5 PCSK9 Mutations Increase Degradation of LDL Receptors, Limiting Binding and Endocytosis ApoB PCSK9 LDL particle LDL receptor LDL receptors degraded at a faster rate by increased PCSK9 activity Normal FH: PCSK9+ Rader DJ, et al. J Clin Invest. 2003;111:

6 APOB Mutations Alter Shape of Apo B Ligand on LDL, Impeding Ability to “Grab” the LDL Receptor ApoB LDL particle LDL receptor Normal FH: APOB- Mutation impairs ApoB- binding ability to LDL receptor Rader DJ, et al. J Clin Invest. 2003;111: